Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 29, 2012 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2011 Financial Results

SAN MATEO, Calif., March 29, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), today reported financial results for the fourth quarter and year ended December 31, 2011, and provided a...
March 26, 2012 20:23 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics to Host a Conference Call to Report 2011 Financial Results and Business Update on March 29, 2012

SAN MATEO, Calif., March 26, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Thursday, March 29, 2012 at 10:00AM PDT, to discuss fourth quarter and full...
March 21, 2012 13:18 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics' Product Candidate Marqibo(R) Receives a Positive Vote From the Oncologic Drugs Advisory Committee (ODAC)

SAN MATEO, Calif., March 21, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), announced the Oncologic Drugs Advisory Committee voted 7 yes, 4 no, and 2 abstain that evidence from...
March 20, 2012 20:13 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics to Host a Conference Call on March 22, 2012 to Discuss the Results of the ODAC Meeting on Marqibo(R)

SAN MATEO, Calif., March 20, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Thursday, March 22, 2012 at 9:00AM PT, to discuss the outcome of the...
February 03, 2012 10:49 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics' Product Candidate Marqibo(R) to be Assessed by Oncologic Drug Advisory Committee (ODAC) on March 21, 2012 With a PDUFA Date of May 13, 2012

SAN MATEO, Calif., Feb. 3, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics Inc. (OTCBB:TLON) announced Marqibo® (vincristine sulfate liposomes injection) is scheduled to be assessed by ODAC on...
January 09, 2012 12:43 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics Announces $11M Financing

SAN MATEO, Calif., Jan. 9, 2012 (GLOBE NEWSWIRE) -- Talon Therapeutics Inc., (OTCBB:TLON), today announced that it has entered into an Investment Agreement with Warburg Pincus and Deerfield...
November 29, 2011 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics Announces First Patient Enrolled in the Phase 3 OPTIMAL>60 Study of Marqibo(R) in Adult Patients With Newly Diagnosed, Aggressive Non-Hodgkin's Lymphoma

Conducted by the prestigious German High-Grade NHL Study Group R-CHMP-14 (M=Marqibo) versus R-CHOP-14 (O=standard vincristine) Powered to demonstrate superior progression-free survival of...
November 14, 2011 17:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics, Inc. Reports Third Quarter 2011 Financial Results

SAN MATEO, Calif., Nov. 14, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc., (OTCBB:TLON), today reported financial results for the three and nine months ended September 30, 2011. "In the third...
November 11, 2011 16:21 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics to Host a Conference Call to Report Third Quarter 2011 Financial Results and Business Update on November 15, 2011

SAN MATEO, Calif., Nov. 11, 2011 (GLOBE NEWSWIRE) -- Talon Therapeutics, Inc. (OTCBB:TLON) will host a conference call on Tuesday, November 15, 2011 at 9:00AM PT, to include a discussion of financial...
September 27, 2011 09:00 ET | Source: Talon Therapeutics, Inc.

Talon Therapeutics' New Drug Application for Marqibo(R) Accepted for Filing by the United States Food and Drug Administration

Accelerated approval review path confirmed by the FDA Prescription Drug User Fee Act (PDUFA) date set for May 13, 2012 SAN MATEO, Calif., Sept. 27, 2011 (GLOBE NEWSWIRE) -- Talon...